Original article excerpt
Server-side extracted preview paragraphs from the original source.
Genmab embraces ChatGPT Enterprise, supported by OpenAI’s commitment to security and privacy
Genmab(opens in a new window), a leading global biotechnology company, is pioneering next-generation antibody therapies to treat cancer and other serious diseases. Their mission is ambitious: to revolutionize patient care with transformative “knock-your-socks-off” (KYSO®) antibody treatments.